KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. Earnings & Forecasts - Benzinga

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc.

KLDOOTCEM

Trade with Public

Trade with Public

$0.2900

At close: Apr 22, 5:00 PM EST

Overview NewsEarnings ForecastFinancials Sentiment Ownership Compare

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. Earnings & Forecasts

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. (KLDO) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. Guidance

Recent Earnings Results

Metric	Q3 '21
Earnings Per Share (Non-GAAP)
Estimate	$-0.54
Actual	$-0.54
Surprise	0.00%
Revenue
Estimate	$170000
Actual	$104000
Surprise	-38.8%

Earnings & Guidance News

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting season.

Shanthi Rexaline

Kaleido Biosciences's Return On Capital Employed Insights

According to Benzinga Pro data, during Q3, Kaleido Biosciences (NASDAQ:KLDO) posted sales of $104.00 thousand. Earnings were up 3.42%, but Kaleido Biosciences still reported an overall loss of $22.41 million.

Benzinga Insights

PRO
Kaleido Biosciences Q3 EPS $(0.54) Up From $(0.65) YoY, Sales $104.00K Down From $482.00K YoY

Kaleido Biosciences (NASDAQ:KLDO) reported quarterly losses of $(0.54) per share. This is a 16.92 percent increase over losses of $(0.65) per share from the same period last year. The company reported $104.00 thousand

Benzinga Newsdesk

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)

Shanthi Rexaline

Mid-Afternoon Market Update: Dow Jumps 450 Points; Comtech Telecommunications Shares Slide

Toward the end of trading Tuesday, the Dow traded up 1.36% to 34,464.68 while the NASDAQ rose 1.68% to 14,494.86. The S&P also rose, gaining 1.52% to 4,365.85.

Lisa Levin

Mid-Day Market Update: Crude Oil Rises 2%; UpHealth Shares Plunge

Midway through trading Tuesday, the Dow traded up 1.25% to 34,429.02 while the NASDAQ rose 1.42% to 14,458.35. The S&P also rose, gaining 1.33% to 4,357.69.

Lisa Levin

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved